Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP928809.RAcQLSilp4-73V3YZsb_EADNSijUWSrYeLr4WW8vzhYjw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP928809.RAcQLSilp4-73V3YZsb_EADNSijUWSrYeLr4WW8vzhYjw130_assertion type Assertion NP928809.RAcQLSilp4-73V3YZsb_EADNSijUWSrYeLr4WW8vzhYjw130_head.
- NP928809.RAcQLSilp4-73V3YZsb_EADNSijUWSrYeLr4WW8vzhYjw130_assertion wasGeneratedBy ECO_0000203 NP928809.RAcQLSilp4-73V3YZsb_EADNSijUWSrYeLr4WW8vzhYjw130_provenance.
- NP928809.RAcQLSilp4-73V3YZsb_EADNSijUWSrYeLr4WW8vzhYjw130_assertion wasDerivedFrom befree-20150227 NP928809.RAcQLSilp4-73V3YZsb_EADNSijUWSrYeLr4WW8vzhYjw130_provenance.
- NP928809.RAcQLSilp4-73V3YZsb_EADNSijUWSrYeLr4WW8vzhYjw130_assertion SIO_000772 8100604 NP928809.RAcQLSilp4-73V3YZsb_EADNSijUWSrYeLr4WW8vzhYjw130_provenance.
- NP928809.RAcQLSilp4-73V3YZsb_EADNSijUWSrYeLr4WW8vzhYjw130_assertion evidence source_evidence_literature NP928809.RAcQLSilp4-73V3YZsb_EADNSijUWSrYeLr4WW8vzhYjw130_provenance.
- NP928809.RAcQLSilp4-73V3YZsb_EADNSijUWSrYeLr4WW8vzhYjw130_assertion description "[The expression of the multidrug resistance (MDR-1) gene product, P-170 glycoprotein (P-170) was investigated in 26 patients with low-risk (n = 9) or high-risk (n = 17) myelodysplastic syndrome (MDS), using a panel of monoclonal antibodies to P-170 (C219, JSB1, C494, MRK16) and quantitative analysis of MDR-1 mRNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP928809.RAcQLSilp4-73V3YZsb_EADNSijUWSrYeLr4WW8vzhYjw130_provenance.